Cargando…

Annexin Expression in Cholangiocarcinoma, and Metastatic Pancreatic Ductal Adenocarcinoma “Is it be Helpful for Differential Diagnosis of These Tumors in the Liver?”

BACKGROUND & OBJECTIVE: Differential diagnosis between cholangiocarcinoma (CCA) and metastatic pancreatic ductal adenocarcinoma (PDA) in the liver is difficult and so far, no specific immunohistochemical marker is reported to differentiate these two tumors. Considering the existing literature, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geramizadeh, Bita, Sehat, Mahsa, Mehrmozayan, Azam, Shojazadeh, Ali Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Society of Pathology 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463754/ https://www.ncbi.nlm.nih.gov/pubmed/34567193 http://dx.doi.org/10.30699/IJP.20201.138489.2512

Ejemplares similares

Diagnostic Value of Arginase-1 and Glypican-3 in Differential Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma and Metastatic Carcinoma of Liver
por: Geramizadeh, Bita, et al.
Publicado: (2015)

Novel PRKAG2 variant presenting as liver cirrhosis: report of a family with 2 cases and review of literature
por: Beyzaei, Zahra, et al.
Publicado: (2021)

De Novo Donor Specific Antibody and Long-Term Outcome After Liver Transplantation: A Systematic Review and Meta-Analysis
por: Beyzaei, Zahra, et al.
Publicado: (2020)

FOXF1 as an Immunohistochemical Marker of Hilar Cholangiocarcinoma or Metastatic Pancreatic Ductal Adenocarcinoma. Single Institution Experience
por: Hrudka, Jan, et al.
Publicado: (2021)

Novel mutations in the PHKB gene in an iranian girl with severe liver involvement and glycogen storage disease type IX: a case report and review of literature
por: Beyzaei, Zahra, et al.
Publicado: (2021)

PKM2 is not required for pancreatic ductal adenocarcinoma
por: Hillis, Alissandra L, et al.
Publicado: (2018)

Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma
por: Topham, James T., et al.
Publicado: (2022)

P16 and P53 Expression in Esophageal Squamous Cell Carcinoma: A Brief Report From The Experience of South of Iran, and Review of the Literature
por: Geramizadeh, Bita, et al.
Publicado: (2021)

Precursor Lesions of Cholangiocarcinoma: A Clinicopathologic Review
por: Geramizadeh, Bita
Publicado: (2020)

Expression of novel tumor markers of pancreatic adenocarcinomas in intrahepatic cholangiocarcinomas
por: Zong, Meijuan, et al.
Publicado: (2013)

Thrombospondin-2 as a diagnostic biomarker for distal cholangiocarcinoma and pancreatic ductal adenocarcinoma
por: Byrling, J., et al.
Publicado: (2021)

The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma
por: Houg, Demi S., et al.
Publicado: (2018)

Applied precision medicine in metastatic pancreatic ductal adenocarcinoma
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
por: Gautam, Shailendra K., et al.
Publicado: (2023)

N-Cadherin Distinguishes Intrahepatic Cholangiocarcinoma from Liver Metastases of Ductal Adenocarcinoma of the Pancreas
por: Gerber, Tiemo S., et al.
Publicado: (2022)

A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
por: Macias, Rocio I.R., et al.
Publicado: (2020)

Pancreatic ductal adenocarcinoma and distal cholangiocarcinoma: a proposal of preoperative diagnostic score for differential diagnosis
por: Muttillo, Edoardo Maria, et al.
Publicado: (2021)

A Survival Model in Locally Advanced and Metastatic Pancreatic Ductal Adenocarcinoma
por: Wang, Yi, et al.
Publicado: (2018)

Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma
por: Raj, Deepak, et al.
Publicado: (2019)

Estimating Metastatic Risk of Pancreatic Ductal Adenocarcinoma at Single-Cell Resolution
por: Chen, Sina, et al.
Publicado: (2022)

Real-Life Results of Palliative Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma
por: Varzaru, Bianca, et al.
Publicado: (2023)

Pancreatic ductal adenocarcinoma in colonic wall: metastatic disease or cancerized pancreatic ectopic tissue?
por: Gallo, Graziana, et al.
Publicado: (2020)

The consistencies and inconsistencies between distal cholangiocarcinoma and pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
por: Lv, Tian-Run, et al.
Publicado: (2022)

Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
por: Lian, Yunyu, et al.
Publicado: (2023)

Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment
por: Gkountakos, Anastasios, et al.
Publicado: (2023)

Cell-to-cell interaction analysis of prognostic ligand-receptor pairs in human pancreatic ductal adenocarcinoma
por: Suzuki, Sayaka R., et al.
Publicado: (2021)

The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver Metastases
por: Wu, Linxia, et al.
Publicado: (2022)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Models of pancreatic ductal adenocarcinoma
por: Dennaoui, Rayane, et al.
Publicado: (2021)

CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma
por: Teodorczyk, M, et al.
Publicado: (2015)

Cholangiocarcinoma Secondary to Primary Sclerosing Cholangitis in Explanted Livers: A Single-Center Study in the South of Iran
por: Geramizadeh, Bita, et al.
Publicado: (2015)

MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma
por: Oto, Julia, et al.
Publicado: (2020)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
por: Pezzilli, Raffaele, et al.
Publicado: (2011)

The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma
por: Luan, Hong, et al.
Publicado: (2022)

Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in mice
por: Thomas, Stacy K., et al.
Publicado: (2023)

Phase 1 dose-escalation study of momelotinib, a Janus kinase 1/2 inhibitor, combined with gemcitabine and nab-paclitaxel in patients with previously untreated metastatic pancreatic ductal adenocarcinoma
por: Ng, Kimmie, et al.
Publicado: (2018)

Screening of an annexin‐A2‐targeted heptapeptide for pancreatic adenocarcinoma localization
por: Ma, Heyao, et al.
Publicado: (2022)

Successful Secondary Engraftment of Pancreatic Ductal Adenocarcinoma and Cholangiocarcinoma Patient-Derived Xenografts After Previous Failed Primary Engraftment()
por: Hernandez, Matthew C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sbrqb1v54sm67u0es4592k4qmg